ReleaseWire Connect

908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, and research partners at the University of North Carolina at Chapel Hill (UNC-CH) continue to make waves on the analytical event circuit with revolutionary High Pressure Mass Spectrometry (HPMS) technology. Professor J. Michael Ramsey and his team from (UNC-CH) delivered a total of 12 presentations at this year’s HPLC and ASMS conferences touting new performance breakthroughs in HPMS. These presentations demonstrate that the collaboration between the Ramsey group and 908 Devices continues to push the boundaries and capabilities of truly handheld mass spectrometry.

908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, announces the successful completion of performance testing for the M908 handheld mass spectrometer. MRIGlobal, a not-for-profit leading contract research and test facility for government and industry, carried out testing at its independent test facility in Kansas City. M908 performance was tested using chemical warfare agents (CWA) and simulants, toxic industrial compounds (TICs) and environmental pollutants. The evaluation concludes ‘The device routinely performed at or exceeded expectations for all test categories.’

908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, is delighted to introduce M908, the world’s first and only handheld tool utilizing high-pressure mass spectrometry (HPMS) for trace-level chemical detection and identification. Engineered to provide civilian users, first responders, and military teams with unique capabilities for material analysis, M908 is set to transform the way chemical and explosive hazards are controlled at the point of need.

908 Devices, an innovator in point-of-need chemical analysis, is delighted to announce that M908, the world’s first and only handheld high pressure mass spectrometer, has been voted first place winner in The Analytical Scientist Innovation Awards 2013. The awards select a single winner and recognize a short-list of the top 15 advances from across the broad field of analytical sciences. Showcasing the wide range and level of progress across the industry, the awards include diverse breakthroughs as 3D Gas Chromatography systems, live cell RNA detection innovations and new laboratory MS platforms. In singling out 908 Devices’ initial product, the award demonstrates the impact small, simple and robust mass spec analysis will have for first responders in safety and security and HAZMAT applications today as well as the future transformative impact HPMS will have on a range of research and industrial applications.

908 Devices has received $7M in Series B funding, which included new investment from Schlumberger and follow-on investments from ARCH Venture Partners, Razor’s Edge Ventures and University of Tokyo Edge Capital (UTEC).

908 Devices, an innovator in point-of-use chemical analysis, continues to benefit from its research partnership with the group of Prof. J. Michael Ramsey at the University of North Carolina at Chapel Hill (UNC-CH). The Ramsey team made a total of eight research presentations at the American Society of Mass Spectrometry Conference in June, all advancing the rapidly evolving field of High Pressure Mass Spectrometry (HPMS™).

SEO UK908 Devices, an innovator in point-of-use chemical analysis, is pleased to announce that Kevin Hrusovsky, former President of Life Sciences and Technology at PerkinElmer, has recently joined its board of directors. With over 25 years’ experience delivering leadership strategy in the life sciences industry, the addition of Kevin Hrusovsky represents a significant benefit to the company.

908 Devices, an innovator in field-portable chemical analysis, today announced it has entered into a strategic partnership with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. The investment will contribute to 908 Devices’ efforts to build rugged, handheld mass spectrometry tools that can perform hazardous chemical detection and analysis. The technology is being developed, in part, with funding from the Department of Homeland Security Science and Technology Directorate, an IQT customer agency.

On Sci-Fi television, in real forensic crime laboratories, and in analytical laboratories around the world, the technique of Mass Spectrometry is the well-established gold standard for food safety testing, explosives and chemical threat forensics, biotechnology research, drugs-of-abuse testing and clinical diagnostics. This broad utility comes both from Mass Spec’s high selectivity (it is able to differentiate millions of different chemicals) and from its extreme sensitivity (it is able to measure quantities as low as 1 part in a billion or better). Unlike television, until now, complexity, large size, and high costs restricted these capabilities to highly skilled scientists in laboratory environments. Samples, if they could be collected and moved, had to be transported to the instruments.

908 Devices, an innovator in field-portable chemical analysis, announces the closing of an $8.1M Series A investment led by ARCH Venture Partners with participation from Razor’s Edge Ventures and University of Tokyo Edge Capital (UTEC). Keith Crandell, Co-founder and Managing Director of ARCH and Mark Spoto, Managing Director of Razor’s Edge have joined 908 Devices’ board.